Merck wrote drug studies for doctors
New York Times, April 17, 2008
Drug maker Merck drafted dozens of research studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to a report. The report provides a look in the industry practice of ghostwriting medical research studies that are then published in academic journals. The authors of the study say it raises broad questions about the validity of much of the drug industry's published research, because the ghostwriting practice appears to be widespread.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- IOM Identifies GME Problems, Calls for Finance Changes
- Revenue Cycles Get a Boost from Simple JPEG Files
- Healthcare Costs Start With What We Eat
- CA Fines 8 Hospitals for Medical Errors
- Handshaking Spreads Germs. Get Over It.
- Centralizing the Revenue Cycle Protects the Bottom Line